<DOC>
	<DOCNO>NCT01095770</DOCNO>
	<brief_summary>The purpose study 3 fold : - 1 . To compare efficacy complication rate 2 widely use method , conventional irrigation tip ablation catheter ( LASSO ) Ablation Frontiers ablation technology , AF ablation PAF . 2 . To evaluate Reveal XT ILR long term accurate AF monitoring device compare 'gold standard ' DDD pacemaker Holter . 3 . To accurately evaluate , continuous rhythm monitoring 1 year , efficacy AF ablation therapy PAF .</brief_summary>
	<brief_title>Left Atrial Ablation With Permanent Pacemaker ImplanTable Loop Recorder Follow-UP</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patient age 1680 year old . Symptomatic PAF AF episodes self terminate least 30 second longer 24 hour . Preference give patient AF episodes lasting longer 4 hour . PAF fail least one drug therapy medical therapy . Patients must give write informed consent form prior participate study . Patient suffer unstable angina last 1 week . Patient myocardial infarction within last 2 month . Patient expect major cardiac surgery within last 2 month . Patient participate conflict study . Patient mentally incapacitate consent comply followup . Patient NYHA class III/ IV heart failure . Patients severe valvular ventricular dysfunction . Pregnancy . Patient suffers cardiac rhythm disorder . Recent coronary artery intervention factor suggest clinical instability ( ECG , clinical laboratory finding )</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Atrial Fibrillation Ablation</keyword>
	<keyword>Atrial Fibrillation monitoring</keyword>
	<keyword>Ablation Frontiers</keyword>
	<keyword>Reveal XT</keyword>
	<keyword>LASSO</keyword>
</DOC>